Cervical cancer is the most common malignancy in Indian women. It usually spreads locally or via regional lymphatics to retroperitoneal lymph nodes and hematogenous spread is rare. The occurrence of skeletal muscle metastases is a very rare event and only a few cases have been reported in literature. The authors present an unusual case of cervical carcinoma in a patient that presented with skeletal muscle metastasis 1 year after the treatment.
INTRODUCTION
Metastasis of carcinoma cervix to skeletal muscles is a rare occurrence. Muscles are highly resistant to primary and metastatic cancer due to their high contractile activity, local changes in pH, oxygenation, accumulation of metabolites, blood flow, and local temperature. [1] Psoas, iliopsoas, paraspinal muscles, and proximal musculature of the upper and lower limbs, represent the most frequently involved sites. Malignancies known to metastasize frequently to the muscle are melanoma, kidney, lung, thyroid cancer, lymphoma, leukemia and colon cancer. [2] We report a case of carcinoma cervix with metastasis to paraspinal and intercostal skeletal muscle as the initial sign of dissemination.
CASE REPORT
A post-menopausal female, married for 45 years with two children, presented with a complaint of white discharge per vagina for 3 months. On local examination, cervix was completely destroyed by a proliferative growth involving both the right and left fornix and the lower third of the vagina. Both the right and left parametrium were indurated to the lateral pelvic wall. Ultrasonography of the abdomen was suggestive of 8.6 cm × 5.3 cm large solid heterogeneous mass with scattered calcification in the cervical region. Histopathology from the growth revealed moderately differentiated squamous cell carcinoma. Metastatic workup did not show any metastatic lesion in liver or lungs. Thus, a diagnosis of carcinoma cervix IIIb (Federation of Gynecology and Obstetrics stage) was made. Then, the patient was planned for concurrent chemotherapy and radiotherapy. She was given radical radiotherapy to the whole pelvis with external beam radiotherapy to a dose of 60 Gy/30 over a period of 6 weeks. She also received 6 cycles of weekly cisplatin concurrently (30 mg/m 2 intravenous). Intracavitary boost was not given as both the fornices were flushed, and vagina was small and conical. The patient remained locoregionally controlled for 1 year, after which she presented with complaints of swelling in the left side of the back along with pain. On examination, a large tender swelling was seen on left paraspinal region, size around 8 cm × 4 cm, hard and fixed. Vaginal examination performed at the time showed growth over cervix extending to involve upper 2/3 of the vagina, and both the parametrium were involved. Contrast-enhanced computed tomography (CT)-thorax revealed a huge mass in the left paraspinal muscles, involving the vertebrae along with multiple lung secondaries [ Figure 1 ]. Fine-needle aspiration cytology (FNAC) from back mass revealed metastatic squamous cell carcinoma [ Figure 2 ]. The patient was advised for palliative local radiotherapy to vertebra followed by chemotherapy, but patient declined treatment and went home and succumbed to the disease.
DISCUSSION
The incidence of metastasis to skeletal muscles is < 1% of all hematogenous metastasis despite the fact that the muscles represent 50% of total body mass in a person. [2] Cancer cell survival is found more in denervated muscle, which is unable to contract rather than those stimulated one. [3] Skeletal muscle involvement from cervical cancer is very rare. [4] Since 2008, only 10 cases with muscle metastasis from cervical cancer have been reported in literature. Deleted the third mention of the fact that the most common site of muscle metastasis is psoas. [5, 6] Various imaging modalities have been used to identify metastasis to muscle, but none of them are specific in differentiating carcinomas, sarcomas and other muscle disorders. CT scans show muscle metastasis as muscle enlargement but cannot specify this as malignant. Magnetic resonance imaging (MRI) in metastatic lesions show low to intermediate intensity on T1-weighted images, high intensity on T2-weighted images, and enhancement on gadolinium. [7] Our patient declined an MRI scan. Differentiation between a primary sarcoma and metastatic carcinoma is difficult without a biopsy/FNAC.
[8] The FNAC was done, which showed metastasis from squamous cell carcinoma in the muscles. Primary squamous cell carcinoma in muscle is not recognized, and thus we have concluded that this is a metastasis from the past diagnosis of cervical cancer.
The outcome of the patients with skeletal metastasis is usually poor mostly due to diffuse metastasis and a lack of consensus on treatment options. When exercised, treatment options include radiotherapy, chemotherapy, and surgery according to the site number and extension of the lesion. In the case of a solitary skeletal muscle metastasis, metastasectomy has been performed, followed by radiotherapy. [4] The general consideration of skeletal muscle metastasis usually requires chemotherapy, in particular, the platinum-taxane combination is often chosen because of high response rate documented with this regimen as compared to cisplatin alone. [10] Palliative radiotherapy or combined radiotherapy and chemotherapy are effective in controlling pain and size of the metastatic lesion. [9] A reason for the prevalence (I have changed incidence to prevalence) of skeletal muscle metastasis in cervix cancer being low may be due to difficulty in differentiating malignant from benign lesions. Thus, in a patient with the previous history of cancer presenting with soft tissue mass, skeletal muscle metastasis should be considered and should be confirmed with imaging modalities and FNAC/biopsy. On confirmation palliative chemotherapy with or without local radiotherapy for pain should be given.
Muscular pain or weakness or just a palpable mass in a patient with a history of cervical cancer should always raise the suspicion of the metastatic muscular disease even after many years of locally controlled disease.
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